Health

Statement, May 2017

South Centre Statement to the 10th NAM Health Ministerial

Below is a statement made by the South Centre’s Deputy Executive Director Vicente Paolo B. Yu III during the meeting of the Ministers of health of the Non-Aligned Movement held in Geneva on 23 May 2017 in conjunction with the World Health Assembly.

(more…)

Research Paper 77, May 2017

Access to Hepatitis C Treatment: A Global Problem

“Viral hepatitis is an international public health challenge, comparable to other major communicable diseases, including HIV, tuberculosis and malaria. Despite the significant burden it places on communities across all global regions, hepatitis has been largely ignored as a health and development priority until recently”. – WHO, Global Health Sector strategy on viral Hepatitis 2016-2021: Towards ending viral hepatitis

(more…)

Policy Brief 39, May 2017

Highlights of the WHO Executive Board: 140th Session

The World Health Assembly (WHA), the highest body of the World Health Organization, will be meeting from 22-31 May 2017.

Earlier in January, the Executive Board of the WHO met and discussed on various strategic issues that will be carried forward to the WHA.

In this light, the South Centre has prepared a timely summary report in the form of a policy brief of the discussions that took place at the EB, to assist delegates and other stakeholders in their preparation for the discussions in the WHA.

(more…)

Policy Brief 37, March 2017

The Need to Avoid “TRIPS-Plus” Patent Clauses in Trade Agreements

A recent article in a prestigious journal reminds us of how the intellectual property chapter of free trade agreements can prevent the sick from getting treatment.  This article also critiques the TPP clauses and warns that they should not be translated to national laws or copied into other FTAs being negotiated. 
(more…)

Analytical Note, March 2017

The TRIPS and WTO Negotiations: Stakes for Africa

This paper discusses the current negotiation issues in the context of the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) and the position the African Group has taken in these negotiations. (more…)

Research Paper 74, February 2017

Mitigating the Regulatory Constraints Imposed by Intellectual Property Rules under Free Trade Agreements

IP provisions in FTAs may have implications on a wide range of public policy areas. A vast academic literature has addressed the “flexibilities” available under the TRIPS Agreement and the negative impact of FTAs in relation to access to medicines. (more…)

Policy Brief 36, February 2017

Gandhi: Walking with us today

Gandhi, his writings and his words are as relevant as ever today as when he lived.   This is the theme of the Sixth Gandhi Memorial Lecture presented by Gurdial Singh Nijar, a prominent Malaysian lawyer and former law professor, and organised by the Gandhi Memorial Trust, Malaysia.   The text of the lecture, which was presented in Kuala Lumpur in October 2016, is published in this policy brief.

(more…)

Statement, January 2017

South Centre Statement on the Amendment to the WTO TRIPS Agreement to Ease Access to Affordable Medicine

An amendment to the TRIPS Agreement that aims to facilitate the access to affordable medicines has entered into force upon approval by two thirds of the WTO members. The amendment reflects the recognition by WTO Members of the need for the continued enhancement of global intellectual property rules to allow Members to systematically take measures to protect public health.

(more…)

Policy Brief 34, December 2016

Air pollution — the silent top global cause of death and of climate change

New research is showing that air pollution is a powerful if silent killer, causing 6.5 million worldwide deaths as well as being the major cause of climate change. (more…)

Statement, October 2016

South Centre Statement to the 18th session of WIPO Committee on Development and Intellectual Property

The following is the statement delivered on 31 October 2016 by the South Centre to the World Intellectual Property Organization’s (WIPO) Committee on Development and Intellectual Property (CDIP) at its eighteenth session. The Centre highlights the importance of the WIPO Development Agenda.

(more…)

Statement, September 2016

Statement by the South Centre on the Report of the UN Secretary-General’s High Level Panel on Access to Medicines released on 14 September 2016

The South Centre endorses the report of the United Nations Secretary General’s High Level Panel on Access to Medicines and its call on governments, the United Nations entities and others including the World Trade Organization, to take action on the report’s recommendations. (more…)

Policy Brief 29, September 2016

Tackling Antimicrobial Resistance: Challenges for Developing Countries

On 21 September 2016,  a High Level Meeting was held on antimicrobial resistance at the sides of the United Nations General Assembly. It was followed by the adoption of a political declaration. This declaration paves the way for new coordinated actions on antimicrobial resistance backed by higher political commitment, on the basis of the Global Action Plan on Antimicrobial Resistance (GAP) of the World Health Organization (WHO).  (more…)


CHF 0.000 items